Sign inJoin waitlistJoin the waitlist

Scott Tagawa

Professor of Medicine · Cornell Univ Joan and Sanford I Weill Med Coll

Credentials: · · · · · ·

History

Cornell Univ Joan and Sanford I Weill Med Coll
Present
New York Presbyterian Hospital
Present

Keck Medicine of USC
2001–2003
Internal Medicine
1998–2001
Keck Sch of Med of the Univ of Southern Calif
1994–1998
Georgetown University

Research

Integrative clinical genomics of advanced prostate cancer
Cell · 2015 · 2,800 citations
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine · 2021 · 2,264 citations
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Nature Medicine · 2016 · 1,436 citations

David Nanus
74 papers
Himisha Beltran
46 papers · 2 as a fellow
Joseph Osborne
32 papers · 1 as a resident
Cora Sternberg
31 papers
Juan Mosquera
29 papers
NB
Neil Bander
29 papers
Ana Molina
27 papers
MM
Michael Morris
25 papers
Oliver Sartor
21 papers · 1 as a fellow
BR
Brian Robinson
20 papers · 1 as a resident
Daniel Petrylak
19 papers
Douglas Scherr
18 papers

Grants

Optimization of Strategies to Improve NCI-Sponsored Clinical Trial Participation Throughout the Weill Cornell Medicine - Meyer Cancer Center Sphere
National Cancer Institute · R50
Contact PI · $584.3K · Weill Medical Coll of Cornell Univ
2024–2029
Comprehensive Assessment of Cancer Theranostics Response
National Cancer Institute · R44
PI · $2M · Aiq Global Inc
2023–2026

Clinical trials

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Principal investigator · Recruiting · Phase 1, Phase 2
Weill Medical College of Cornell University
2021–2029
Re-treatment 225Ac-J591 for mCRPC
Principal investigator · Completed · Early phase 1
Weill Medical College of Cornell University
2020–2024
177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC
Principal investigator · Terminated · Phase 1, Phase 2
Weill Medical College of Cornell University
2018–2020
Phase I Trial of 225Ac-J591 in Patients With mCRPC
Principal investigator · Completed · Phase 1
Weill Medical College of Cornell University
2017–2023